Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis

OBJECTIVE: Current non-invasive diagnostic tests can distinguish between pancreatic cancer (pancreatic ductal adenocarcinoma (PDAC)) and chronic pancreatitis (CP) in only about two thirds of patients. We have searched for blood-derived metabolite biomarkers for this diagnostic purpose. DESIGN: For a...

詳細記述

保存先:
書誌詳細
出版年:Gut
主要な著者: Mayerle, Julia, Kalthoff, Holger, Reszka, Regina, Kamlage, Beate, Peter, Erik, Schniewind, Bodo, González Maldonado, Sandra, Pilarsky, Christian, Heidecke, Claus-Dieter, Schatz, Philipp, Distler, Marius, Scheiber, Jonas A, Mahajan, Ujjwal M, Weiss, F Ulrich, Grützmann, Robert, Lerch, Markus M
フォーマット: Artigo
言語:Inglês
出版事項: BMJ Publishing Group 2018
主題:
Pancreas
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5754849/
https://ncbi.nlm.nih.gov/pubmed/28108468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2016-312432
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料